Original Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 14, 2012; 18(14): 1602-1609
Published online Apr 14, 2012. doi: 10.3748/wjg.v18.i14.1602
Figure 6
Figure 6 Effect of inhibitor, pyrrolidinedithiocarbamate, on basic fibro-blast growth factor protein expression. Administration of pyrrolidinedithiocarbamate (PDTC) (50 μmol/L) reinforced the toxicarioside A (4.5 μg/mL)-induced downregulation of basic fibroblast growth factor (bFGF). Results are depicted as mean ± SE of three independent experiments. aP < 0.05 vs control group.